Where Will Vertex Pharmaceuticals Be in 5 Years
A lot can change in five years. Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech company's approved products focused on one indication – cystic fibrosis (CF). And Vertex's market cap was nearly half what it is today.
It's reasonable to assume that much will change for the company by 2030 as well. Where will Vertex Pharmaceuticals be in five years? Here's my best guess.
Image source: Vertex Pharmaceuticals.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
€406.95
-0.760%
With 39 Buy predictions and not a single Sell prediction Vertex Pharmaceuticals Inc. is an absolute favorite of our community.
As a result the target price of 455 € shows a slightly positive potential of 11.81% compared to the current price of 406.95 € for Vertex Pharmaceuticals Inc..
